{"product_id":"complex-interventional-cardiovascular-therapy-2021","title":"Complex Interventional Cardiovascular Therapy 2021","description":"\u003ch1 class=\"detail-title\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003eComplex Interventional Cardiovascular Therapy 2021 \u003c\/span\u003e\u003c\/h1\u003e\n\u003cp class=\"detail-title\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e - 14th Annual Conference: A Case Based Workshop is organized by cme4u GmbH Congresses, Meetings and Education and will be held from Jul 16 - 17, 2021 at InterContinental Chicago Magnificent Mile, Chicago, Illinois, United States of America.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"details-desc\"\u003e\n\u003cdiv\u003e\n\u003cstrong\u003eWho Should Attend:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe CICT workshops have been designed to meet the educational needs of interventional cardiologists, non-invasive cardiologists and cardiology fellows along with cath lab nurses and technicians and other medical professionals who care for patients undergoing catheter-based cardiovascular interventions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eAccreditation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe\u003cem\u003e CMEsolutions\u003c\/em\u003e designates this live activity for a maximum of 16.75 \u003cem\u003eAMA PRA Category 1 Credits.™\u003c\/em\u003e\u003cstrong\u003e \u003c\/strong\u003ePhysicians should claim only the credit commensurate with the extent of their participation in the activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eDescription:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eThe goal of the CICT Conferences is to promote high quality, patient-centered, clinical and technical decision-making in the field of Interventional Cardiovascular Medicine. The uniqueness of the CICT conferences lies in the open forum transparent discussion of controversial topics allowing free flowing interaction between audience and faculty. The content of these meetings addresses a wide range of complex cardiovascular interventional topics that still present a challenge to the clinician with respect to choosing the appropriate therapy (surgery vs. catheter-based therapy) and with respect to using optimal technique to ensure the safety and efficacy of the procedure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eLearning Objectives:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eUpon conclusion of this program, participants should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e• Demonstrate patient-centered evidence-based decision-making at the individual patient level.\u003c\/li\u003e\n\u003cli\u003e• Explain the skill set necessary to triage patients with complex coronary and structural heart disease to surgical vs. endovascular intervention.\u003c\/li\u003e\n\u003cli\u003e• Discuss cognitive and technical skills to maximize success and reduce complications in complex cardiovascular interventions.\u003c\/li\u003e\n\u003cli\u003e• Identify best practices to prevent and manage complications in coronary and structural heart disease interventions.\u003c\/li\u003e\n\u003cli\u003e• Exercise hands-on technical training for percutaneous cardiac structural procedures.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003ch1\u003elist\u003c\/h1\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003col\u003e\n\u003cli\u003eCICT-2021.pdf\u003c\/li\u003e\n\u003cli\u003eCOMPLEX MULTIVESSEL CAD – Case conclusion Naveed Adoni, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCOMPLEX MULTIVESSEL CAD – Case introduction A Patient with complex 3 vessel CAD (intermediate and highSYNTAX score) Naveed Adoni, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCOMPLEX MULTIVESSEL CAD – Follow the evidence (the ISCHEMIA trial)…Try medical therapy first! Rajiv Gulati, MD, PhD.mp4\u003c\/li\u003e\n\u003cli\u003eCOMPLEX MULTIVESSEL CAD – In stable CAD, does complete revascularization tip the balance in favor of an invasive strategy- the ISCHEMIA Gregg Stone, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCOMPLEX MULTIVESSEL CAD – Let’s be more nuanced.FFR guided PCIDES simplifies complexity and yields better outcome! Habib Samady, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCOMPLEX MULTIVESSEL CAD – Q \u0026amp; A.mp4\u003c\/li\u003e\n\u003cli\u003eCOMPLEX MULTIVESSEL CAD – The evidence is clear.Old fashion CABG is associated with better survival! Aziz Ghaly, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHOW TO REVASCULARIZE COMPELX CTOs – How to revascularize a long LCX occlusion (40 mm) Tim Fischell, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHOW TO REVASCULARIZE COMPELX CTOs – How to revascularize a tortous and calcified RCA CTO Mark Ricciardi, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHOW TO REVASCULARIZE COMPELX CTOs – How to revascularize an ostial LAD CTO Khaldoon Alaswad, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHOW TO REVASCULARIZE COMPLEX SEVERELY CALCIFIED LESIONS – PCI in severely calcified and tortous RCA My first choice is orbital atherectomyCase-based presentation Ramzan Zakir, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHOW TO REVASCULARIZE COMPLEX SEVERELY CALCIFIED LESIONS – PCI in severely calcified CAD My first choice is still rotational atherectomy Case-based presentation Sanja Mehta, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHOW TO REVASCULARIZE COMPLEX SEVERELY CALCIFIED LESIONS – Shockwave balloon lithotripsy How did it change my approach to calcified lesions Case-based presentation Richard Shlofmitz.mp4\u003c\/li\u003e\n\u003cli\u003eInnovations in Device-Based Heart Failure Therapy – Innovations in cardiac electrophysiologic therapeutics Ken Stein, MD.mp4\u003c\/li\u003e\n\u003cli\u003eInnovations in Device-Based Heart Failure Therapy – Innovations in renal artery ablation Horst Sievert, MD.mp4\u003c\/li\u003e\n\u003cli\u003eInnovations in Device-Based Heart Failure Therapy – Innovations in sensors and cardiac neuromodulation Kalyanam Shivkumar, MD.mp4\u003c\/li\u003e\n\u003cli\u003eInnovations in Device-Based Heart Failure Therapy – Innovations in structural heart disease interventions Horst Sievert, MD.mp4\u003c\/li\u003e\n\u003cli\u003eInnovations in Device-Based Heart Failure Therapy – Q \u0026amp; A.mp4\u003c\/li\u003e\n\u003cli\u003eINTRAVASCULAR IMAGING MECHANISTIC INSIGHTS AND PCI OPTIMIZATION – How does Shockwave balloon lithotripsy work Insights from OCTCase-based presentation Richard Shlofmitz, MD.mp4\u003c\/li\u003e\n\u003cli\u003eINTRAVASCULAR IMAGING MECHANISTIC INSIGHTS AND PCI OPTIMIZATION – How to use OCT to optimize PCI results and limit contrast use Case-based presentation Bassem Chehab, MD.mp4\u003c\/li\u003e\n\u003cli\u003eINTRAVASCULAR IMAGING MECHANISTIC INSIGHTS AND PCI OPTIMIZATION – Saline OCT Why and HowCase-based presentation Evan Shlofmitz, MD.mp4\u003c\/li\u003e\n\u003cli\u003eLEFT ATRIAL APPENDAGE (LAA) CLOSURE – ICE is an ideal intra procedure imaging modality Case studies Mohamad Alkhouli, MD.mp4\u003c\/li\u003e\n\u003cli\u003eLEFT ATRIAL APPENDAGE (LAA) CLOSURE – Innovations for prevention of air embolism Kalyanam Shivkumar, MD.mp4\u003c\/li\u003e\n\u003cli\u003eLEFT ATRIAL APPENDAGE (LAA) CLOSURE – Pivotal clinical trials of LAAC (LAAOS III trial, ect..) A critical appraisal! Randy Lee, MD.mp4\u003c\/li\u003e\n\u003cli\u003eLEFT ATRIAL APPENDAGE (LAA) CLOSURE – What is the best sizing strategy Echo, angiography, CTA, 3D printing Case studies Jacqueline Saw, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePFO AND ASD CLOSURE – How to tailor closure device to anatomy Case studies Vaikom Mahadevan, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePFO AND ASD CLOSURE – PFO closure for migraine Will there be a resurrection! Jonathan Tobis, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – Genotype-Guided P2Y12 selection should be the gold standard to guide post DES antiplatelet therapy Naveen Pereira, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – I never use manual aspiration in STEMI Here is why! Giora Weisz, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – Pre-procedure Cangrelor should be utilized more often in selected patients Here is why! George Dangas, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – Pre-procedure IIbIIIa should be utilized more often in selected patients Here is why! Arnold Seto, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – The universe of post DES Ticagrelor vs. Prasugrel controversy A critical appraisal of the evidence! Roxana Mehran, MD.mp4\u003c\/li\u003e\n\u003cli\u003ePHARMACOLOGICAL AND DEVICE-BASED MANAGEMENT IN ACUTE CORONARY SYNDROMES – Why I use mechanical thrombectomy with Penumbra CAT RX in acute myocardial infarction Darshan Doshi, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – A paradigm shift is overdue! CTA -FFR is the new gold standard for initial ischemia evaluation Jonathon Leipsic, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – Case conclusion John Blair, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – Case presentation A diagnostic journey of a patient! John Blair, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – CT-FFR in real life Pros and Cons! Case-Based Presentation Varinder Singh, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – Q \u0026amp; A.mp4\u003c\/li\u003e\n\u003cli\u003eSHOULD CORONARY CTA REPLACE STRESS TESTING FOR DIAGNOSIS OF CAD – The evidence speaks for itself Invasive FFR remains the gold standard Habib Samady, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSTENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – All available 3rd generation DES are similarly effective in reducing thrombotic risk John Messenger, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSTENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – Alternative access in cardiogenic shock for mechanical support devices in patients with PAD Amir Kaki, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSTENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – DAPT duration in complex PCI Do the standard trials apply Jennifer Tremmel, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSTENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – DAPT for 4 weeks is safe and effective Jorge Saucedo, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSTENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – Does the choice of DOACs matter in patients with stable coronary artery disease George Dangas, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSTENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – Protected PCI in a patient with complex CAD and severe aortic stenosis Ashok Chaudhary, MD.mp4\u003c\/li\u003e\n\u003cli\u003eSTENT DESIGN AND DAPT DURATION IN PATIENTS AT HIGH BLEEDING RISK – Rotational atherectomy and protected PCI in a patient with complex severely calcified CAD and reduced LVEF Giora Weisz, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTAVR HOW-TO WORKSHOP – How to optimize deployment of the evolute pro valveCase studies Maurice Buchbinder, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTAVR HOW-TO WORKSHOP – How to optimize TAVR for bicuspid aortic valve procedures Tarun Chakravarty, MD_2.mp4\u003c\/li\u003e\n\u003cli\u003eTAVR HOW-TO WORKSHOP – How to optimize TAVR for valve-in-valve proceduresCase studies Ron Waksman, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTAVR HOW-TO WORKSHOP – How to optimize TAVR in patients with low coronary ostiaCase studies Vaikom Mahadevan, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTAVR HOW-TO WORKSHOP – How to optimize TAVR safely in patients with severely calcified annulus LVOT Case studies Raj Makkar, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTAVR HOW-TO WORKSHOP – Interventional structural electrophysiology – TAVR predicting risk of complete heart block \u0026amp; how to pace Kalyanam Shivkumar, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTAVR HOW-TO WORKSHOP – Optimizing difficult iliofemoral access in patients with severe iliac disease role of lithotripsy and covered stentsCase st.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – How to tailor MitraClip device choice to complex anatomy NTR, XTR, NTRW, XTRWCase studies Gagan Singh, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – The Carillon device technique and outcomes Steve Goldberg, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – The Pascal device technique and outcomes Charles Davidson, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – TMVR – valve-in-valve patient selection, device sizing, and deployment technique Case studies Tarun Chakravarty, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – Trans-septal puncture technologies and techniques Case studies Samir Kapadia, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER MITRAL VALVE REPAIR REPLACEMENT – Trans-septal puncture technologies and techniquesCase studies Samir Kapadia, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER TRICUSPID VALVE REPAIR – ICE is an ideal intra procedure imaging modality for Tricuspid repair Case studies Mohamad Alkhouli, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER TRICUSPID VALVE REPAIR – Transcatheter tricuspid valve repair (TriClip) Patient selection, imaging, and outcomes studies Samir Kapadia, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER TRICUSPID VALVE REPAIR – Tricuspid annuloplasty (The Cardioband) What have we learned so far Patient selection, imaging, and outcomes Case studies C.mp4\u003c\/li\u003e\n\u003cli\u003eTRANSCATHETER TRICUSPID VALVE REPAIR – Tricuspid valve replacement Repair pipeline Azeem Latib, MD.mp4\u003c\/li\u003e\n\u003cli\u003eUNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE – Case conclusion Ramzan Zakir, MD.mp4\u003c\/li\u003e\n\u003cli\u003eUNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE – Case introduction A patient with left main coronary artery disease and low anatomic complexity Ramzan Zakir, MD.mp4\u003c\/li\u003e\n\u003cli\u003eUNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE – In the aftermath of the EXCEL trial PCI is preferable to CABG! Gregg Stone, MD,.mp4\u003c\/li\u003e\n\u003cli\u003eUNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE – In the aftermath of the NOBEL trial CABG is preferable to PCI! Steven Bailey, MD.mp4\u003c\/li\u003e\n\u003cli\u003eUNSETTLED TAVR TOPICS – Balloon expandable vs. self expandable valves competitive or complimentary platforms Azeem Latib, MD.mp4\u003c\/li\u003e\n\u003cli\u003eUNSETTLED TAVR TOPICS – Cerebral protection with TAVR State of the evidence Samir Kapadia, MD.mp4\u003c\/li\u003e\n\u003cli\u003eUNSETTLED TAVR TOPICS – TAVR for aortic regurgitation Tips $ TricksCase studies Raj Makkar, MD.mp4\u003c\/li\u003e\n\u003cli\u003eUNSETTLED TAVR TOPICS – When transfemoral access is not an option what’s your 2nd and 3rd access choiceCase studies Ron Waksman, MD.mp4\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954349183074,"sku":"MED-AMB01715","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Complex-Interventional-Cardiovascular-Therapy-2021.jpg?v=1779374464","url":"https:\/\/meducourse.com\/products\/complex-interventional-cardiovascular-therapy-2021","provider":"Meducourse","version":"1.0","type":"link"}